Advanced Search
Contact | Corporate | Help

A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis

Sponsors:
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Cystic Fibrosis
Age Groups:
  • Child
Gender:
Both
Names:
  • Drug: Nutropin AQ [somatropin (DNA origin) injection]
Enrollment:
68

Additional information about NCT00079742.


SourceSolution © 2008-2012